세계의 통증 한랭요법 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global Cold Pain Therapy Market size is anticipated to grow from USD 2.79 Billion in 2024 to USD 4.57 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.63% during the forecast period of 2026 to 2033.

The Cold Pain Therapy market is on the cusp of transformative growth, driven by an increasing prevalence of chronic pain conditions and a growing awareness of non-invasive pain management solutions. As healthcare providers and patients alike seek alternatives to pharmacological treatments, cold therapy has emerged as a preferred method for alleviating pain and inflammation. This market encompasses a diverse range of products, including cold packs, cryotherapy devices, and topical analgesics, all designed to provide effective relief without the side effects associated with traditional pain medications.

Technological advancements are further propelling the Cold Pain Therapy market, with innovations such as portable cryotherapy devices and smart cold therapy solutions gaining traction. These devices not only enhance user convenience but also offer precise temperature control, allowing for tailored treatment regimens that cater to individual patient needs. Additionally, the integration of digital health technologies, such as mobile applications that track pain levels and treatment efficacy, is expected to enhance patient engagement and adherence to therapy. As the market continues to evolve, manufacturers that prioritize user-friendly designs and evidence-based efficacy will likely capture a larger share of the growing consumer base.

Furthermore, the Cold Pain Therapy market is witnessing a shift towards holistic pain management approaches, with an increasing emphasis on combining cold therapy with other modalities such as physical therapy and exercise. This integrative approach not only addresses the immediate symptoms of pain but also promotes long-term recovery and improved quality of life. As healthcare systems increasingly adopt multidisciplinary strategies for pain management, the demand for cold therapy solutions will continue to rise. In this context, companies that foster collaborations with healthcare professionals and invest in clinical research will be well-positioned to lead the market and contribute to the evolving landscape of pain management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product

• OTC Products (Gels, Ointments and Creams, Sprays and Foams, Patches, Roll-Ons, Cold Packs, Others)
• Prescription Products (Motorized Devices, Non-motorized Devices)

By Application

• Musculoskeletal Disorder
• Post-operative
• Sports Medicine
• Post-trauma Therapy

By Therapy type

• Icepack Therapy
• Chamber Therapy
• Cryosurgery

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• E-Commerce
• COMPANIES PROFILED
• Sanofi
• 3M
• ROHTO Pharmaceutical Co. Ltd.
• DJO LLC
• Medline Industries Inc.
• Unexo Laboratories Pvt. Ltd.
• Bruder Healthcare Company LLC.
• Hot and Cold Company
• Polar Products Inc.
• Medichill UK Ltd.
• Medtronic
• Romsons Sustaining the Life Force
• MeyerDC
• Hisamitsu Pharmaceutical Co. Inc.
• Breg Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. COLD PAIN THERAPY INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Therapy type
  • 3.7.4 Market Attractiveness Analysis By Distribution Channel
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL COLD PAIN THERAPY MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. OTC Products (Gels, Ointments and Creams, Sprays and Foams, Patches, Roll-Ons, Cold Packs, Others) Historic and Forecast Sales By Regions
• 5.4. Prescription Products (Motorized Devices, Non-motorized Devices) Historic and Forecast Sales By Regions

6. GLOBAL COLD PAIN THERAPY MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Musculoskeletal Disorder Historic and Forecast Sales By Regions
• 6.4. Post-operative Historic and Forecast Sales By Regions
• 6.5. Sports Medicine Historic and Forecast Sales By Regions
• 6.6. Post-trauma Therapy Historic and Forecast Sales By Regions

7. GLOBAL COLD PAIN THERAPY MARKET ANALYSIS BY THERAPY TYPE

• 7.1. Overview By Therapy type
• 7.2. Historical and Forecast Data Analysis By Therapy type
• 7.3. Icepack Therapy Historic and Forecast Sales By Regions
• 7.4. Chamber Therapy Historic and Forecast Sales By Regions
• 7.5. Cryosurgery Historic and Forecast Sales By Regions

8. GLOBAL COLD PAIN THERAPY MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 8.1. Overview By Distribution Channel
• 8.2. Historical and Forecast Data Analysis By Distribution Channel
• 8.3. Hospital Pharmacy Historic and Forecast Sales By Regions
• 8.4. Retail Pharmacy Historic and Forecast Sales By Regions
• 8.5. E-Commerce Historic and Forecast Sales By Regions

9. GLOBAL COLD PAIN THERAPY MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE COLD PAIN THERAPY COMPANIES

• 10.1. Cold Pain Therapy Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF COLD PAIN THERAPY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Sanofi
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. 3M
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. ROHTO Pharmaceutical Co. Ltd.
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. DJO LLC
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Medline Industries Inc.
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Unexo Laboratories Pvt. Ltd.
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Bruder Healthcare Company LLC.
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Hot And Cold Company
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Polar Products Inc.
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Medichill UK Ltd.
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Medtronic
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Romsons Sustaining The Life Force
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. MeyerDC
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. Hisamitsu Pharmaceutical Co. Inc.
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Breg Inc
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies